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ABSTRACT
Methodsfordeterminingprotein–proteininteractions
in mammalian cells typically rely on single reporter
functions and are susceptible to variations between
samples particularly in regard to levels of transcrip-
tion, processing and translation. A method has been
developed for determining protein–protein interac-
tions in mammalian cells, which bypasses these
variables confounding single reporter assays. The
approach utilizestwo units ofgene expression linked
to reporter functions that are interposed by a
deactivation–activation unit in such a way that the
downstream expression unit is switched off. Hence
upstream expression occurs regardless of protein–
protein interaction, leading to the production of the
upstream reporter. In the event of protein–protein
interactions, the downstream expression unit is
switched on leading to dual reporter read outs. Thus,
theratioofthetworeporteractivitiesprovidesameas-
uretodeterminetheefficiencyofprotein–proteininter-
actions. To access the system we screened a mutant
ofBMPR2wheretheinteractionbetweenBMPR-IIand
LIMK is abrogated. BMPR-II is a type II receptor of the
TGFb superfamily and plays a key role in the patho-
genesis of familial pulmonary arterial hypertension.
Thissystemhaspotentialforhigh-throughputscreen-
ing of libraries (peptide, chemical, cDNA, etc.) to isol-
ate agents that are capable of interfering with highly
selective protein–protein interaction.
INTRODUCTION
Protein–protein interactions are common in most biological
processes in cells. Perturbed interactions contribute to the
development of many pathological states (1–4). Elucidation
of protein–protein interactions contributes to the characteriza-
tion of the function of novel proteins and hence the genes that
encode them. Methods for investigation of protein–protein
interactions include biophysical, computational, biochemical
and genetic approaches. For the identiﬁcation of multi-protein
complexes and to determine their association and dissociation
rates together with sites of interactions, methods based on
surface plasmon resonance (SPR) (5) and different types of
mass spectrometry (MS) have been employed (6–8). These
methodsareproventobeuseful,although puriﬁcation,sequen-
cing and identiﬁcation of novel proteins can be limiting espe-
cially when present only in small quantities. Computational
methods based on various principles, including correlated
changes of amino acid sequence between interacting protein
domains (9), properties related to interface topology, solvent
accessible area (ASA) (10,11) that estimates sites of interac-
tion and primary structure and associated physiochemical
properties (12), each can predict interactions. While these
predictive methodologies are informative in so much as
they provide an indication of the afﬁnity of a given protein
for another protein, they all require further experimental
validation.
One of the most commonly used methods to determine
novel protein–protein interactions is the yeast two-hybrid sys-
tem (13). This system exploits the fact that transcription fac-
tors are comprised of two functional domains, a DNA binding
domain and a transcription activation domain. The DNA bind-
ing domain recognizes a speciﬁc DNA sequence whilst the
activation domain facilitates the recruitment of Polymerase II
associated transcription complex and initiates transcription of
the downstream gene. In this system the protein domains are
separated from each other until brought together by two inter-
acting proteins. This system has been widely used to screen
pray-expression libraries for proteins that interact with a bait
protein. The system is prone to contamination by false posit-
ives (interactions that are difﬁcult to validate) and false neg-
atives (interactions that are not detected). Bait proteins that
alone activate or repress the expression of the reporter gene
can also prove problematic.
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system, alternative approaches have been developed. One such
example is the split-ubiquitin system (14). Ubiquitin, a small
protein, is necessary for proteosome degradation. Proteins of
interest are fused to C- and N-terminal domains of ubiquitin.
In the event of protein–protein interactions an active ubiquitin
(‘split-ubiquitin’) is reconstituted. Ubiquitin is recognized by
ubiquitinspeciﬁcprotease,whichleadstothereleaseofreporter
protein. Additional technologies, based on the yeast two-hybrid
screen are being developed all the time. These include systems
based on signalling (15) and dual-bait (16). Each of these modi-
ﬁcations has a major limitation as many mammalian proteins
are exposed to signiﬁcant post-translational modiﬁcations,
important in protein–protein complex formation and function.
Inan attemptto overcome these difﬁculties mammalianver-
sionsofthetwo-hybridscreenhavebeendeveloped(17–20)but
these have been single reporter functions and are hence sus-
ceptible to variation between samples of levels of transfection
and transcription. We have developed a dual reporter assay
system based on yeast two-hybrid screen, which comprised
two autonomous units of gene expression. The upstream unit
is expressed regardless of protein–protein interactions. In the
absence of interacting proteins the downstream unit is swit-
ched off.Intheeventofaninteraction,thedownstreamexpres-
sion unit is also activated and hence both reporter proteins are
produced. Thus, the ratio of the two reporter activities can be
used as a reference value to detect mutations or trans-acting
factors that might affect protein–protein interactions.
MATERIALS AND METHODS
Plasmid construction
Construction of the reporter plasmids (pTN114 and pTN110)
wasbasedonpBLUGA(21),whichcontainsreadingframesfor
theb-galactosidaseandluciferasegenes.ToconstructpTN114,
a deactivation–activation (D/A) unit was cloned into XhoI/SalI
and BglII/BamHI sites of pBPLUGA. The unit comprises a
translation termination signal for the upstream reporter fol-
lowed by a 30 end trimming and polyA tail addition site
(AATAAA), an upstream activation sequence of Saccharomy-
ces cerevisiae (22) linked to a TATA box sequence from aden-
ovirusE1bminimalpromoter(23),sixcopiesofbindingsitesfor
GAL4 transcription factor (24) and a synthetic mRNA splicing
signalforeffectiveexpressionofthedownstreamreporter,a50-
UTRandanin-framestartcodonforthedownstreamreporter.A
DNAfragmentcontainingtheactivationsequences,TATAbox,
GAL4 binding site and the splicing signal that comprised nuc-
leotides 1–535 of pGAL/lacZ (Invitrogen) was ampliﬁed using
UASF(Xho) 50-CCGCTCGAGGGTGAAATAAAGTCGAC-
CCGAGCTCTTACGCGGG-30 and UASR(BglII) 50-GAAA-
GATCTTGCCATGTCTTCGATCTGCAGAATTCC-30. For
cloning purposes the internal XhoI site was replaced by a
BamHI site using site directed mutagenesis (25). The plasmid
pTN110wasconstructedbycloningtheXhoI–BamHIfragment
that comprised nucleotides 1–202 into SalI and BamHI sites of
pBPLUGA. The resulting plasmid did not contain the poly-
adenylation site and the splicing signal.
The construct pTN111 was made by cloning the Gal4 DNA
binding domain (residues 1–147) (26) with a N-terminal T7
epitope tag into AﬂII and KpnI sites of pcDNA3.1 (Invitrogen).
The coding region of LIMK1 gene (NM_002314) was sub-
cloned into KpnI and XbaI sites ofpTN111. Construct pTN112
was constructed by cloningthe VP16 transcriptional activation
domain (27) into XbaI and ApaI sites of pcDNA3.1 (Invitro-
gen).A translation termination site was incorporated at the end
ofVP16activation domain. The coding sequences ofBMPR-II
[NM_001204 and NM_033346 for long (LF) and short forms
(SF), respectively] and D485G mutant were cloned into
BamHI and EcoRI sites of pTN112.
The dual ﬂuorescence reporter was constructed by cloning
the deactivation–activation unit into XhoI and BamHI sites of
pDsRed-TN24-GFP (Siskoglou and Nasim, unpublished data).
This vector was similar to pTN24 (28) except that the genes
encoding b-galactosidase and luciferase were replaced by
genes encode for ﬂuorescence proteins and the SV40 promoter
was replaced by the CMV promoter. The D/A unit is similar to
that used in pTN114 except that an additional SV40 polyA site
comprising nucleotides 1498–1648 of the DsRed-Express-C1
(Clonetech) was introduced at the 50 end of the upstream
activation sequence.
Gene transfer, cell culture, enzymatic assay,
fluorescence microscopy and flow cytometry
HEK-293 (human embryonic kidney) cells were transiently
transfected with relevantplasmids using Gene Jammer (Strata-
gene). Cells were harvested 48 h after transfection and
b-galactosidase and luciferase activities were measured
using Dual Light System (Applied Biosystems) as described
elsewhere (28,29). For live cell imaging, cells were grown as
before and the images were taken under a ﬂuorescence micro-
scope (TE 300, Nikon). The images were analysed using
Openlab software (Improvision). For single-cell expression,
cells expressing both green and red ﬂuorescences were selec-
ted using a FACScan ﬂow cytometer (Becton Dickinson) and
the ﬂuorescence intensities were measured using Cellquest
software.
RESULTS
The general principle ofthe method isoutlined inFigure1. We
have constructed a set of reporter constructs in which genes
encoding b-galactosidase and luciferase are fused with a
recombinant fragment containing the translation termination
signal for the upstream reporter, a polyadenylation site, an
upstream activation sequence linked to a TATA box sequence
from adenovirus E1b minimal promoter, six copies of binding
sites for GAL4 transcription factor, a pre-mRNA splicing sig-
nal,a50-untranslated region(50-UTR) andin-framestartcodon
for the downstream reporter. Upon transfection into the mam-
maliancells, transcriptionfromthe SV40promoterleadstothe
production of a pre-mRNA which contains a translation ter-
mination signal and a polyadenylation signal. Efﬁcient pro-
cessing and termination (transcription and translation) would
result in the production of b-galactosidase protein. In the event
of protein–protein interactions, transcription of the luciferase
gene would be activated, the mRNA would be exported to
the cytoplasm resulting in the production of luciferase protein.
Since luciferaseactivitywouldbeproducedonlyafterprotein–
proteininteractions,whereasb-galactosidaseisexpressedcon-
stantly, the ratio of luciferase and b-galactosidase activities
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To test the ability of the assay system, HEK 293 cells were
transfected with a reporter plasmid pTN114. Asecondplasmid
(pTN110) was generated as identical to pTN114 except for the
absence of signals for polyadenylation and splicing. After 48 h
cells were harvested and b-galactosidase and luciferase activ-
ities were measured. Cells transfected with either plasmid
produced only b-galactosidase activity (Figure 2B). Upon
co-transfection with plasmids encode for the murine p53
(pCR2.1/p53 produced a Gal4-p53 fusion protein) and SV
40 large T antigen (pCR2.1/LgT produced a VP16-LgT fusion
protein), the plasmid pTN114 was able to produce both
b-galactosidase and luciferase activities, whereas pTN110
failed to show any luciferase activity (Figure 2A and B).
The plasmids encoding p53 and LgT were purchased from
Invitrogen for their known interactions. Co-transfection with
plasmids containingthe p53 andthe polyoma viral coat protein
(CP) (pCR2.1/VP16-CP generated by Invitrogen produced a
VP16-CP fusion protein), failed to produce a signiﬁcant
amount of luciferase activity (Figure 2A). The luciferase and
b-galactosidaseactivitieswerehighlyvariablebetweenexperi-
ments whereas when the data was expressed as the ratio of
luc–gal activities, the variability was signiﬁcantly reduced
(Figure 2C). The presence of luciferase protein was conﬁrmed
by western blotting using Luciferase HRP conjugate antibody
(Ab Cam, UK) (data not shown).
Mutations in the type II receptors for bone morphogenetic
protein (BMPR-II), a member of the TGF-b receptor family
underlie the majority of inherited forms of primary pulmonary
hypertension (PPH) (30) and familial pulmonary arterial
hypertension (31). BMPR-II is a multi-domain protein con-
taining extracellular, transmembrane, kinase and cytoplasmic
tail domains. The mutations are dispersed all over the
functional domains and are likely to impinge upon receptor
mediated function. A number of proteins have been shown to
interact with BMPR-II (8). The interactions between LIM
kinase 1 (LIMK1) and BMPR-II were initially discovered
by yeast two-hybrid screening and conﬁrmed by immuno-
precipitation in mammalian cells (32). We wished to examine
whether we could employ the reporter system to examine the
interactions of LIMK1 and BMPR-II. This would provide the
basis of a rapid assay system to investigate the effects of
mutations in the BMPR2 on receptor-mediated function.
We employed the system to screen mutants of BMPR-II
where protein–protein interactions might be abrogated. We
constructed a series of constructs where the coding sequence
of LIM kinase 1 gene was fused with a N-terminal DBD and
the BMPR2 gene was fused with anactivation domain atthe C-
terminal end. Both proteins were either T7 or myc tagged so
that they could be easily puriﬁed. Co-transfection of plasmids
encoding both proteins along with the reporter plasmid
(pTN114) into the mammalian cells enabled both proteins
to interact with each other giving rise to a luc–gal ratio
(Figure 2D). Co-transfection of plasmids encode for the
LIMK1 and SF of the BMPR2 or missense mutation produced
signiﬁcantly reduced luc–gal ratio (Figure 2D). The expres-
sion of LIMK1 and BMPR-II proteins was conﬁrmed using
antiT7 and anti-myc antibodies, respectively, by means of
western blotting (data not shown).
In order to establish a system for high-throughput screening
of libraries (chemical, peptide, cDNA, etc.) a dual ﬂuores-
cence reporter was constructed using genes encoding red
(DsRed Express) and green ﬂuorescence proteins (GFP).
DsRed Express and GFP were chosen as their excitation
peaks are 488 and 557 nm, respectively and therefore they
can be easily distinguished under a ﬂuorescence microscope.
In addition, each is a highly stable protein, exhibiting no
detectable photoinstability with high signal-to-noise ratio (33)
and a shorter maturation time than that of other ﬂuorescence
Poly A-DBD6-TATA-Splicing unit-5’UTR
Reporter B D/A unit pA SV40 Reporter A
Transcription, processing and translation
No interaction
Interactions
Reporter A
Reporter B
Reporter A
pA
Figure 1. The dual-light reporter system for determining protein–protein interactions is based on two reporter genes, which are fused via a recombinant fragment
containingasyntheticdeactivaion/activation(D/A)unit.Theunitcomprisespolyadenylationsignal(s),sixcopiesofGal4DNAbindingsite,aTATAbox,asynthetic
splicing unit. Upon transfection into mammalian cells the reporter A is transcribed under the control of SV40 promoter, while transcription of the reporter B is
switchedoff.Intheeventofprotein–proteininteractions,transcriptionofthereporterBisactivatedandbothreportersareexpressed.50-UTRsareindicatedbyfilled
bars while the pA denotes polyadenylation signals.
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Figure 2. Analysesofthegal–lucreportersystemtodetermineprotein–proteininteractionsinmammaliancells.Thereporterconstructalongwithrelevantplasmids
wasco-transfectedintoHEK293cellsandactivitiesofluciferase(A)andb-galactosidase(B)weremeasured.Theratioofbothreporteractivitieswasnormalizedtoa
value of 100 (C) with p53 and LgT and (D) with LIMK1 and BMPR2. The standard deviations are indicated by error bars.
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Figure 3. AnalysesofthedualfluorescencereporterintoHEK293cells.(A)TheexpressionofGFPwassuppressedintheabsenceofinteractingproteinsasshown,
wherecellsweretransfectedwith(i)reporteralone,orco-transfectedwith(ii)p53and(iii)LgT.TheexpressionoftheGFPisactivatedwhencellswereco-transfected
with plasmidsencoding the p53 and CP (iv and v). (B) Fluorescenceintensitiesof both proteinswere measured and normalizedas mentionedin Figure 2. Mean and
standard deviations were derived from a pool of 30 to 40 randomly selected cells.
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malian cells the reporter plasmid produced only the upstream
reporter (DsRed Express) (Figure 3A). Co-transfections of
plamids containing either p53 or LgT gene were unable to
initiate transcription of the green ﬂuorescence protein. Over-
expression of both genes (in this case p53 and LgT) initiated
transcription of the GFP. Expanded view revealed that both
proteins were co-localized. We investigated the degree of
interactions in a living cell. Cells expressing both proteins
were randomly selected and ﬂuorescence intensities were
measured. Quantiﬁcation of the ﬂuorescence ratio indicated
that the extent of interactions was uniform in a population of
cells (Figure 3B). We also determined the extent of interaction
in single cell. Signiﬁcant amount of green ﬂuorescence intens-
ity was observed when cells were transfected with both p53
and LgT genes but not with the LgTalone (Figure 4A and B), a
ﬁnding consistent with the data obtained from ﬂuorescence
microscopy.
DISCUSSION
Since the conventional methods based on the yeast two-hybrid
system for assaying protein–protein interactions in mamma-
lian cells are susceptible to numerous variables, we developed
a system that bypassed the variables that affect single reporter
assays. One of the important features of this system is that a
synthetic deactivation–activation unit is created which com-
prises signals for transcription, polyadenylation, processing
and translation. Signals for polyadenylation, transcription
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Figure 4. Single-cell assayfor the dualfluorescence reporter. Cells transfected with the reporter along with the respectiveplasmids as mentionedabove. Cells with
both fluorescence activities were selected using a fluorescence activated cell sorter and their intensities were determined (A) and normalized (B). The mean and
standard deviations were derived from 300 to 400 cells.
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upstream reporter is expressed. Upon protein–protein interac-
tions the Pol II transcription machinery is recruited upstream
of the second reporter, hence enabling the production of the
second reporter. We have previously showed that there is a
good correlation between the level of transcript and
luciferase–galactosidase ratio (28).
We have analysed the inter-experiment variability for
expression of the reporter proteins and found substantial scat-
ter of the data points. However, by taking advantage of con-
stitutive expression of reporter A, we can correct the
expression of reporter B to this reference standard. Hence,
the ratio of two reporter activities show marked reduction
in the signal variability (Figure 2C). We have tested the
dual-light reporter in several ways to show that it reﬂects
the efﬁciency of protein–protein interactions. The highest
ratio of luciferase and galatosidase activities was observed
when co-transfection was carried out using plasmids encoding
the p53 with LgT and the BMPR2 with LIMK1 (Figure 2C and
2D), as these proteins interact with each other (32,34,35). The
lowest ratio was observed when either the reporter (pTN114)
was transfected alone or co-transfected with plasmids encod-
ing the p53 with CP and the LIMK1 with short or mutant form
of BMPR2. The interactions among these proteins are very
weak (32,35). We observed that the interaction between
LIMK1 and BMPR-II was weaker than that of LgT and
p53, possibly due to mislocalization of BMPR-II. Luciferase
activity was completely abolished when the polyadenylation
and splicing signals were ablated (pTN110). Co-transfections
of the p53 and LgT had no discernible effects possibly due to
transcriptional interference, a process that is known to affect
the expression of downstream gene (36). In this case, upon
transcription from the SV40 promoter a gal–luc fusion RNA
was produced. The presence of translation termination signal
at the end of b-galactosidase gene prompted the production of
b-galactosidase protein. We would assume that in the case of
pTN114, transcription termination occurred at poly A sites
located at the end of both reporter genes (37). Both RNAs
were polyadenylated, bound by Poly A binding protein
(PABP), circularized by interacting with translation initiation
complex (38) and thereby acted as autonomous units of
expression.
A potential complication of the approach was that of tran-
scriptional interference, which might affect recruitment of
transcription complex for the second reporter. This could be
easily addressed by inserting multiple termination sites (36) at
the end of ﬁrst reporter as transcription termination occurs
through a non-processive mechanism (39). We have not
determined the level of promoter suppression by which the
expression of the downstream reporter could be affected but
again this could be tackled by interposing MAR/SAR ele-
ments (40) between the adjacent units. Although we have not
encountered the problems of autoactivation of library screen-
ing (41), it is unlikely to affect the usefulness of the method,
as long as a second independent method (i.e. pull-down,
immunoprecipitation) is used to validate the most interesting
candidates that emerge from a screen.
Protein–protein interactions have a great potential as a tar-
get for therapeutic inoculation. Identiﬁcation of a small
molecule that dimerizes two proteins can be used for induction
of cell proliferation (42) and apoptosis (43). On the contrary,
small molecule antagonists of proteins can be useful in devel-
oping antibiotic, antiviral and antiparasitic drugs (44). The
advantages of the dual ﬂuorescence reporter are that the assay
is measured directly on the intact cell and therefore does not
require cell wall disruption or addition of a substrate and the
sensitivity of this assay is comparable with that reported for
luc–gal assay. In addition the dual ﬂuorescence assay could be
performed in 96- or 386-well format and would be useful to
screen chemical or peptide libraries to identify dimerizers or
antagonists that affect speciﬁc protein–protein interactions. In
this case it would be advantageous to set up a stable mamma-
lian cell line by incorporating the ﬂuorescence reporter. The
maturation time of the DsRed Express is shorter than that of
its DsRed counterpart, which makes the reporter system useful
in investigating protein interactions in the early stages of
developing embryos.
Although we have only shown that this system would
be useful in screening mutations of BMPR-II that are involved
in LIMK interactions, there are a number of other human
diseases for which it would be beneﬁcial to isolate drugs
capable of targeting selected protein–protein interactions.
This system in its present form would be useful, for example,
in identifying proteins that interact with selenoprotein N.
Mutations in the selenoprotein N gene have been implicated
in muscular dystrophy (45). The classical two-hybrid screen
to identify the interacting proteins is not suitable because
yeast is known to contain no selenocysteine incorporation
machinery. Other methods, such as pull-down or immuno-
precipitation, would be difﬁcult due to the fact that seleno-
cysteine incorporation in mammalian cell line is an inefﬁcient
process (46).
We earlier developed a dual-reporter based assay system
(28) to determine RNA processing efﬁciency in mammalian
cells. In this system, two reporter activities fused with splicing
signals were linked to single gene expression unit. In the event
of splicing, the expression unit produced a fusion protein with
two reporter functions whereas inefﬁcient splicing produced a
protein with single reporter function. The system presented
here is based on two autonomous gene expression units where
one expression unit is expressed regardless of the expression
of the other unit. The other unit is switched on upon efﬁcient
protein–protein interactions. We have shown here the useful-
ness of this principle in upgrading a classical two-hybrid
screen. We suggest that this principle may be beneﬁcial for
other systems where the activities are limited to single reporter
functions.
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